loading page

Postural orthostatic tachycardia syndrome following SARS-CoV-2 infection and COVID-19 vaccination: A comparative review
  • +4
  • Mohammad Barary,
  • Zeinab Mohseni Afshar,
  • Homa Mazaherinia,
  • Hossein Nazari Rostami,
  • Arefeh Babazadeh,
  • Erfan Hashemi,
  • Soheil Ebrahimpour
Mohammad Barary
Shahid Beheshti University of Medical Sciences Department of Clinical Nutrition and Dietetics
Author Profile
Zeinab Mohseni Afshar
Kermanshah University of Medical Sciences
Author Profile
Homa Mazaherinia
Iran University of Medical Sciences Nursing Care Research Center
Author Profile
Hossein Nazari Rostami
Shahid Beheshti University of Medical Sciences School of Medicine
Author Profile
Arefeh Babazadeh
Babol University of Medical Science Faculty of Medicine
Author Profile
Erfan Hashemi
Babol University of Medical Science Faculty of Medicine
Author Profile
Soheil Ebrahimpour
Babol University of Medical Science Faculty of Medicine

Corresponding Author:[email protected]

Author Profile

Abstract

The coronavirus disease 2019 (COVID-19) has shown unexpected viral infection traits. Initially thought to affect respiratory health primarily, it also involves the gastrointestinal system. However, many complications during the pandemic were caused by the virus, including neurological, cardiovascular, dermatological, and metabolic issues. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also been linked to cardiac complications, such as myocardial infarction, in individuals without cardiovascular risk factors. SARS-CoV-2 vaccines exacerbated the situation with possible adverse events (AEs). Vaccine side effects, like thromboembolic events, can be life-threatening or simply bothersome. Postural orthostatic tachycardia syndrome (POTS) is a nonlethal cardiac complication seen with COVID-19 and its vaccines. In this review, we summarized the POTS-COVID-19 relationship comprehensively.